Skip to content

Renal Fractional Flow Reserve in Renal Artery Stenting

Prognostic Value of Renal Fractional Flow Reserve in Hypertensive Patients With Renal Artery Stenosis Qualified to Renal Artery Stenting

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01128933
Acronym
PREFFER
Enrollment
45
Registered
2010-05-24
Start date
2006-06-30
Completion date
2010-05-31
Last updated
2010-05-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Renal Artery Stenosis, Hypertension

Keywords

Fractional flow reserve, Revascularization, Prognosis, Hemodynamics, Hypertension

Brief summary

The purpose of the study is to determine potential utility of renal fractional flow reserve in prognosis predicting after renal stent implantation.

Interventions

Sponsors

Ministry of Science and Higher Education, Poland
CollaboratorOTHER_GOV
National Institute of Cardiology, Warsaw, Poland
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

* At least moderate (60% or more) renal artery stenosis with atheromatic appearance in angiography * Hypertension defined according to WHO criteria * Age 18-75 years * Signed informed consent obtained

Exclusion criteria

* Bilateral renal artery stenosis or significant renal artery stenosis in solitary kidney * Contraindications to percutaneous renal angioplasty with stenting * Atrophy of the kidney supplied with stenosed artery * Other well known secondary reason for hypertension * Chronic heart failure NYHA II-IV * Significant valvular heart disease qualified for surgery * Persistent atrial fibrillation * Renal failure with GFR below 30ml/min

Design outcomes

Primary

MeasureTime frame
Blood pressure improvement6 months

Secondary

MeasureTime frame
Kidney function preservation6 months

Countries

Poland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026